Fibrodysplasia ossificans progressiva emerges from obscurity.
Trends in molecular medicine | 2025 | Kaplan FS, Shore EM, Pignolo RJ
[Indexed for MEDLINE] Conflict of interest statement: Declaration of interests F.S.K. is a clinical trial investigator for Ashibio, Incyte, Ipsen, and Regeneron; a coinventor of a US patent (pending) to the Trustees of the University of Pennsylvania on the use of MMP-9 inhibitors for heterotopic ossification; and a member of the Medical Registry Advisory Board of the IFOPA. E.M...